164 related articles for article (PubMed ID: 26456456)
21. C667T and A1298C polymorphisms of methylenetetrahydrofolate reductase gene and susceptibility to myocardial infarction: A systematic review and meta-analysis.
Alizadeh S; Djafarian K; Moradi S; Shab-Bidar S
Int J Cardiol; 2016 Aug; 217():99-108. PubMed ID: 27179899
[TBL] [Abstract][Full Text] [Related]
22. MTHFR polymorphism and the risk of prostate cancer: a meta-analysis of case-control studies.
Li XL; Xu JH
Prostate Cancer Prostatic Dis; 2012 Sep; 15(3):244-9. PubMed ID: 22370724
[TBL] [Abstract][Full Text] [Related]
23. Methylenetetrahydrofolate reductase 677TT genotype may be associated with an increased lung cancer risk in North China: an updated meta-analysis.
Liu NB; Li J; Qi JF; Zhang ZZ; Wu X; Zhang JH
Med Sci Monit; 2014 Dec; 20():2817-23. PubMed ID: 25544260
[TBL] [Abstract][Full Text] [Related]
24. Association of methylenetetrahydrofolate reductase (MTHFR) gene C677T polymorphism with autism: evidence of genetic susceptibility.
Rai V
Metab Brain Dis; 2016 Aug; 31(4):727-35. PubMed ID: 26956130
[TBL] [Abstract][Full Text] [Related]
25. The association between MTHFR gene polymorphisms and hepatocellular carcinoma risk: a meta-analysis.
Qin X; Peng Q; Chen Z; Deng Y; Huang S; Xu J; Li H; Li S; Zhao J
PLoS One; 2013; 8(2):e56070. PubMed ID: 23457501
[TBL] [Abstract][Full Text] [Related]
26. The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and tumor risk: evidence from 134 case-control studies.
Tang M; Wang SQ; Liu BJ; Cao Q; Li BJ; Li PC; Li YF; Qin C; Zhang W
Mol Biol Rep; 2014 Jul; 41(7):4659-73. PubMed ID: 24744129
[TBL] [Abstract][Full Text] [Related]
27. ASSOCIATION OF MTHFR A1298C POLYMORPHISM WITH BREAST CANCER AND/OR OVARIAN CANCER RISK: AN UPDATED META-ANALYSIS.
Liu W; Li Y; Li R; Han X; Ma Y; Liu B; Kong X
Afr J Tradit Complement Altern Med; 2016; 13(5):72-86. PubMed ID: 28487897
[TBL] [Abstract][Full Text] [Related]
28. MTHFR C677T and A1298C polymorphisms were associated with bladder cancer risk and disease progression: a meta-analysis.
You W; Li Z; Jing C; Qian-Wei X; Yu-Ping Z; Weng-Guang L; Hua-Lei L
DNA Cell Biol; 2013 May; 32(5):260-7. PubMed ID: 23578207
[TBL] [Abstract][Full Text] [Related]
29. Association of methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism with preterm delivery and placental abruption: a systematic review and meta-analysis.
Chen J; Chen L; Zhu LH; Zhang ST; Wu YL
Acta Obstet Gynecol Scand; 2016 Feb; 95(2):157-65. PubMed ID: 26439908
[TBL] [Abstract][Full Text] [Related]
30. [Polymorphism of methylenetetrahydrofolate reductase and sensitivity of stomach cancer to fluoropyrimidine-based chemotherapy].
Gao CM; Lu JW; Toshiro T; Wu JZ; Cao HX; Chen HQ; Feng JF; Kazuo T
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Dec; 25(12):1054-8. PubMed ID: 15769364
[TBL] [Abstract][Full Text] [Related]
31. Associations between Methylenetetrahydrofolate Reductase (MTHFR) Polymorphisms and Non-Alcoholic Fatty Liver Disease (NAFLD) Risk: A Meta-Analysis.
Sun MY; Zhang L; Shi SL; Lin JN
PLoS One; 2016; 11(4):e0154337. PubMed ID: 27128842
[TBL] [Abstract][Full Text] [Related]
32. Methylenetetrahydrofolate reductase A1298C polymorphism and diabetes risk: evidence from a meta-analysis.
Yan Y; Liang H; Yang S; Wang J; Xie L; Qin X; Li S
Ren Fail; 2014 Aug; 36(7):1013-7. PubMed ID: 24828322
[TBL] [Abstract][Full Text] [Related]
33. MTHFR genetic polymorphisms may contribute to the risk of chronic myelogenous leukemia in adults: a meta-analysis of 12 genetic association studies.
Li B; Zhang J; Wang L; Li Y; Jin J; Ai L; Li C; Li Z; Mao S
Tumour Biol; 2014 May; 35(5):4233-45. PubMed ID: 24379141
[TBL] [Abstract][Full Text] [Related]
34. Methylenetetrahydrofolate reductase polymorphisms and susceptibility to acute lymphoblastic leukemia in a Chinese population: a meta-analysis.
Xiao Y; Deng TR; Su CL; Shang Z
Oncol Res Treat; 2014; 37(10):576-82. PubMed ID: 25342508
[TBL] [Abstract][Full Text] [Related]
35. Association between MTHFR C677T polymorphism and primary open-angle glaucoma: a meta-analysis.
Huo Y; Zou H; Lang M; Ji SX; Yin XL; Zheng Z; Liu W; Chen CL; Yuan RD; Ye J
Gene; 2013 Jan; 512(2):179-84. PubMed ID: 23123730
[TBL] [Abstract][Full Text] [Related]
36. Relevance of methylenetetrahydrofolate reductase gene variants C677T and A1298C with response to fluoropyrimidine-based chemotherapy in colorectal cancer: a systematic review and meta-analysis.
Zhong L; He X; Zhang Y; Chuan JL; Chen M; Zhu SM; Peng Q
Oncotarget; 2018 Jul; 9(58):31291-31301. PubMed ID: 30131855
[TBL] [Abstract][Full Text] [Related]
37. Aberrant DNA methylation of the P16, MGMT, and hMLH1 genes in combination with the methylenetetrahydrofolate reductase C677T genetic polymorphism and folate intake in gastric cancer.
Lin J; Zeng RM; Li RN; Cao WH
Genet Mol Res; 2014 Mar; 13(1):2060-8. PubMed ID: 24737431
[TBL] [Abstract][Full Text] [Related]
38. Association between C677T and A1298C polymorphisms of the MTHFR gene and risk of male infertility: a meta-analysis.
Yang Y; Luo YY; Wu S; Tang YD; Rao XD; Xiong L; Tan M; Deng MZ; Liu H
Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173242
[TBL] [Abstract][Full Text] [Related]
39. Association between methylenetetrahydrofolate reductase C677T polymorphism and psoriasis: A meta-analysis.
Wu D; Shi D; Yang L; Zhu X
J Dermatol; 2016 Feb; 43(2):162-9. PubMed ID: 26212228
[TBL] [Abstract][Full Text] [Related]
40. Methylenetetrahydrofolate reductase polymorphic variants C677T and A1298C in rectal cancer in Slavic population: significance for cancer risk and response to chemoradiotherapy.
Stanojevic A; Spasic J; Marinkovic M; Stojanovic-Rundic S; Jankovic R; Djuric A; Zoidakis J; Fijneman RJA; Castellvi-Bel S; Cavic M
Front Genet; 2023; 14():1299599. PubMed ID: 38288161
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
